Pacer BioThreat Strategy ETF (VIRS)
| Assets | $3.40M |
| Expense Ratio | 0.70% |
| PE Ratio | 24.58 |
| Shares Out | 100,000 |
| Dividend (ttm) | $0.33 |
| Dividend Yield | 0.95% |
| Ex-Dividend Date | Mar 21, 2024 |
| Payout Ratio | 23.14% |
| 1-Year Return | +15.74% |
| Volume | 3 |
| Open | 33.67 |
| Previous Close | 33.93 |
| Day's Range | 34.55 - 34.55 |
| 52-Week Low | 27.78 |
| 52-Week High | 36.26 |
| Beta | 0.84 |
| Holdings | 55 |
| Inception Date | Jun 24, 2020 |
About VIRS
Fund Home PageThe Pacer BioThreat Strategy ETF (VIRS) is an exchange-traded fund that is based on the LifeSci BioThreat Strategy index. The fund tracks a market-cap weighted index of US companies whose products or services address biological threats to human health. VIRS was launched on Jun 24, 2020 and is issued by Pacer.
Top 10 Holdings
52.25% of assets| Name | Symbol | Weight |
|---|---|---|
| NVIDIA Corporation | NVDA | 7.39% |
| Merck & Co., Inc. | MRK | 5.40% |
| Netflix, Inc. | NFLX | 5.38% |
| Amazon.com, Inc. | AMZN | 5.30% |
| Walmart Inc. | WMT | 5.28% |
| Thermo Fisher Scientific Inc. | TMO | 4.94% |
| Danaher Corporation | DHR | 4.79% |
| Lowe's Companies, Inc. | LOW | 4.71% |
| The Home Depot, Inc. | HD | 4.54% |
| Abbott Laboratories | ABT | 4.52% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 21, 2024 | $0.07697 | Mar 27, 2024 |
| Dec 27, 2023 | $0.08002 | Jan 3, 2024 |
| Sep 21, 2023 | $0.07853 | Sep 27, 2023 |
| Jun 22, 2023 | $0.09238 | Jun 28, 2023 |
| Mar 23, 2023 | $0.06308 | Mar 29, 2023 |
| Dec 22, 2022 | $0.0621 | Dec 29, 2022 |
News
COVID Biotech ETFs Rise At Fever Pace
ETFs that look at a subsector of biotech have significantly outperformed broader biotech funds this year.
These are the ETFs with the most exposure to the year's best-performing stock
Semiconductor behemoth Nvidia Corp. is the biggest gainer in the S&P 500 for the year to date, up 127%, heftily ahead of second-place West Pharmaceuticals Inc. , which has only gained 87%. The exchang...
3 ETFs For Nvidia's Big Arm Holdings Acquisition
News broke Saturday that semiconductor giant Nvidia (NASDAQ: NVDA) is in talks to acquire Arm Holdings, a UK-based chip designer, from Japan's SoftBank Group for $40 billion.
VIRS Makes Pandemic, Vaccine ETF Competition More Interesting
It was just a week ago that the first exchange-traded fund dedicated to vaccine developers, plenty engaged in the fight against the coronavirus, came to market.